Inventor · disambiguated record
Qing Shi
Also filed as: SHI QING
26 granted patents·7 pending applications·180 citations·filing 1999–2019
95Inventor score
Files withBRISTOL MYERS SQUIBB CO9LILLY CO ELI9BLASZCZAK LARRY CHRIS3ELAN PHARM INC3ARNOLD MACKLIN BRIAN1
Top patents by PatentIndex Score
33 records- 0194US8362065B2Carbazole carboxamide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 29, 2013·32 cites·20 claims
- 0293US8084620B2Carbazole carboxamide compounds useful as kinase inhibitorsLIU QINGJIE·Filed 2009·Granted Dec 27, 2011·60 cites·22 claims
- 0390US9815859B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 14, 2017·11 cites·15 claims
- 0489US8586751B2Nicotinamide compounds useful as kinase modulatorsDE LUCCA GEORGE V·Filed 2010·Granted Nov 19, 2013·32 cites·10 claims
- 0585US9334290B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 10, 2016·5 cites·20 claims
- 0680US9637495B2CGRP receptor antagonistsLILLY CO ELI·Filed 2016·Granted May 2, 2017·2 cites·25 claims
- 0775US10138244B2Triazolopyrazinone derivative useful as a human PDE1 inhibitorLILLY CO ELI·Filed 2017·Granted Nov 27, 2018·3 cites·10 claims
- 0875US10023576B2Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 17, 2018·2 cites·10 claims
- 0973US8133907B2Pyridine derivatives as dipeptedyl peptidase inhibitorsBLASZCZAK LARRY CHRIS·Filed 2006·Granted Mar 13, 2012·2 cites·19 claims
- 1071US7186715B2Piperazine- and piperidine-derivatives as melanocortin receptor agonistsLILLY CO ELI·Filed 2002·Granted Mar 6, 2007·6 cites·42 claims
- 1167US10435415B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 8, 2019·0 cites·11 claims
- 1267US2019382416A1Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 1365US10106559B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·11 claims
- 1463US6552013B1Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsELAN PHARM INC·Filed 1999·Granted Apr 22, 2003·13 cites·34 claims
- 1562US7291619B2Melanocortin receptor agonistsLILLY CO ELI·Filed 2002·Granted Nov 6, 2007·2 cites·23 claims
- 1662US6906056B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsLILLY CO ELI·Filed 2003·Granted Jun 14, 2005·0 cites·48 claims
- 1757US6838455B2Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2002·Granted Jan 4, 2005·0 cites·42 claims
- 1857US2016194338A1Substituted tetrahydrocarbazole and carbazoles carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1956US11453673B2Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitorsLILLY CO ELI·Filed 2019·Granted Sep 27, 2022·0 cites·12 claims
- 2056US11401274B2[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetesLILLY CO ELI·Filed 2018·Granted Aug 2, 2022·0 cites·13 claims
- 2156US6569851B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsELAN PHARMACEUTIALS INC·Filed 1999·Granted May 27, 2003·6 cites·76 claims
- 2256US2005192265A1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsFiled 2004·Application pending·0 cites
- 2354US2005192269A1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsFiled 2004·Application pending·0 cites
- 2453US2005267150A1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsTHOMPSON RICHARD C·Filed 2004·Application pending·0 cites
- 2552US11180503B2[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivativesLILLY CO ELI·Filed 2018·Granted Nov 23, 2021·0 cites·12 claims
- 2652US6528505B1Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsELAN PHARM INC·Filed 1999·Granted Mar 4, 2003·4 cites·57 claims
- 2749US6696438B2Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsELAN PHARM INC·Filed 2002·Granted Feb 24, 2004·0 cites·74 claims
- 2845US2007082907A1Peroxisome proliferator activated receptor modulatorsLILLY CO ELI·Filed 2004·Application pending·0 cites
- 2944US8076514B2Phenyl compounds and their use in the treatment of Type II diabetesBLASZCZAK LARRY CHRIS·Filed 2006·Granted Dec 13, 2011·0 cites·17 claims
- 3043US8106090B21-amino linked compoundsBLASZCZAK LARRY CHRIS·Filed 2006·Granted Jan 31, 2012·0 cites·27 claims
- 3139US2006257987A1Ppar modulatorsGONZALEZ VALCARCEL ISABEL CRIS·Filed 2004·Application pending·0 cites
- 3235US10214537B2Bicyclic heteroaryl amine compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 26, 2019·0 cites·9 claims
- 3335US8299061B2Inhibitors of diacylglycerol acyltransferaseARNOLD MACKLIN BRIAN·Filed 2010·Granted Oct 30, 2012·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Qing Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →